670 670 (Diltiazem Extended Release 180 mg)

Pill imprint 670 670 has been identified as Diltiazem hydrochloride extended release 180 mg.

Diltiazem is used in the treatment of atrial fibrillation; high blood pressure; atrial flutter; supraventricular tachycardia; raynaud's syndrome (and more), and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 180 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 670 670

Diltiazem hydrochloride extended release
Imprint:
670
670
Strength:
180 mg
Color:
Green & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Calcium channel blocking agents
Group IV antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Caraco Pharmaceutical Laboratories
National Drug Code (NDC):
47335-0670
Inactive Ingredients:
hypromellose 2910 (5 mPa.s)
magnesium silicate
ethylcelluloses
triethyl citrate
gelatin
titanium dioxide
sodium lauryl sulfate
FD&C Blue No. 1
FD&C Green No. 3
D&C Yellow No. 10

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)